Suven Life Sciences

Small Cap 5.6k Result

₹84.4

2 (2.43%)

As on 30 November, 2023 | 11:27 BSE: 530239 NSE: SUVENISIN: INE495B01038

Suven Life Sciences Performance

Day Range

Low 82.65
High 85.90

₹ 84.4

52 Week Range

Low 45.00
High 88.75

₹ 84.4

Open Price83.00
Previous Close82.40
Volume396831

Start SIP in Suven Life Sciences

Start SIP

Suven Life Sciences Share Price

Over 1 Month 34.07%
Over 3 Month 27.4%
Over 6 Month 47.94%
Over 1 Year 32.81%

Suven Life Sciences Key Statistics

P/E Ratio	-15.9
PEG Ratio	0.7
Market Cap Cr	1,841
Price to Book Ratio	4.9
EPS	-1.3
Dividend	0
Relative Strength Index	54.67
Money Flow Index	61.46
MACD Signal	2.92
Average True Range	3.6

Suven Life Sciences Investment Rating

Master Rating:
Suven Life Sciences has an operating revenue of Rs. 12.47 Cr. on a trailing 12-month basis. An annual revenue growth of 28% is outstanding, Pre-tax margin of -874% needs improvement, ROE of -31% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 29% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 30 which is a POOR score indicating inconsistency in earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Suven Life Sciences Financials

Standalone Consolidated

Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios

Indicator	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Oper Rev Qtr Cr	3	4	3	3	4	4	4
Operating Expenses Qtr Cr	11	11	9	10	12	11	12
Operating Profit Qtr Cr	-8	-7	-6	-7	-7	-7	-7
Depreciation Qtr Cr	2	2	2	2	2	2	1
Interest Qtr Cr	0	0	0	0	0	0	0
Tax Qtr Cr	0	0	0	0	0	0	0
Net Profit Qtr Cr	3	-3	-2	-7	-9	-2	-9

Indicator	Mar 2023	Mar 2022
Total Revenue Annual Cr	22	17
Operating Expenses Annual Cr	41	48
Operating Profit Annual in Cr	-28	-37
Depreciation Cr	7	4
Interest Annual Cr	0	1
Tax Annual Cr	0	0
Net Profit Annual Cr	-20	-36

Indicator	Mar 2023	Mar 2022
Cash from Operating Activity Annual Cr	-10	-37
Cash from Investing Activity Annual Cr	-362	-107
Cash from Financing Annual Activity Cr	396	146
Net Cash Flow Annual Cr	24	2

Indicator	Mar 2023	Mar 2022
Total ShareHolders Funds Annual Cr	853	476
Fixed Assets Annual Cr	37	41
Total Non Current Assets Annual Cr	619	422
Total Current Assets Annual Cr	241	64
Total Assets Annual Cr	860	486

Indicator	Mar 2023	Mar 2022
Book Value Per Share Annual Rs	39	33
ROE Annual %	-2	-8
ROCE Annual %	-3	-7
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %	-143	-264

Indicator	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Oper Rev Qtr Cr	3	4	3	3	4	4	4
Operating Expenses Qtr Cr	27	32	34	55	26	25	24
Operating Profit Qtr Cr	-24	-28	-32	-52	-22	-21	-20
Depreciation Qtr Cr	2	2	2	2	2	2	1
Interest Qtr Cr	0	0	0	0	0	0	0
Tax Qtr Cr	0	0	0	0	0	0	0
Net Profit Qtr Cr	-13	-24	-28	-51	-23	-16	-21

Indicator	Mar 2023	Mar 2022
Total Revenue Annual Cr	22	17
Operating Expenses Annual Cr	139	134
Operating Profit Annual in Cr	-126	-122
Depreciation Cr	7	4
Interest Annual Cr	0	1
Tax Annual Cr	0	0
Net Profit Annual Cr	-118	-122

Indicator	Mar 2023	Mar 2022
Cash from Operating Activity Annual Cr	-103	-128
Cash from Investing Activity Annual Cr	-261	-22
Cash from Financing Annual Activity Cr	396	146
Net Cash Flow Annual Cr	32	-4

Indicator	Mar 2023	Mar 2022
Total ShareHolders Funds Annual Cr	375	96
Fixed Assets Annual Cr	37	41
Total Non Current Assets Annual Cr	137	41
Total Current Assets Annual Cr	252	67
Total Assets Annual Cr	389	108

Indicator	Mar 2023	Mar 2022
Book Value Per Share Annual Rs	17	7
ROE Annual %	-32	-127
ROCE Annual %	-33	-122
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %	-867	-988

Invest in Suven Life Sciences

Suven Life Sciences Technicals

EMA & SMA

Current Price

₹84.4

2 (2.43%)

Bullish Moving Average
___
16

Bearish Moving Average
___
0

EMA SMA

20 Day
₹81.46

50 Day
₹76.88

100 Day
₹72.23

200 Day
₹68.72

20 Day
₹82.66

50 Day
₹75.93

100 Day
₹70.55

200 Day
₹63.81

Suven Life Sciences Resistance and Support

PIVOT

₹83.02

Resistance
First Resistance	83.88
Second Resistance	85.37
Third Resistance	86.23

RSI	54.67
MFI	61.46
MACD Single Line	2.92
MACD	2.38

Support
First Resistance	81.53
Second Resistance	80.67
Third Resistance	79.18

Suven Life Sciences Delivery and Volume

Period	NSE + BSE Volume Avg	NSE + BSE Delivery Volume Avg	NSE + BSE Delivery Volume %
Day	483,928	19,395,834	40.08
Week	425,800	18,096,489	42.5
1 Month	1,300,017	50,674,678	38.98
6 Month	797,245	35,836,175	44.95

Suven Life Sciences Result Highlights

Suven Life Sciences Synopsis

NSE-Medical-Diversified

Suven Life Sciences is involved in the business activities of Other professional, scientific and technical activities. Company’s Total Operating Revenue is Rs. 13.54 Cr. and Equity Capital is Rs. 21.81 Cr. for the Year ended 31/03/2023. Suven Life Sciences Ltd. is a Public Limited Listed company incorporated on 09/03/1989 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1989PLC009713 and registration number is 009713.

Market Cap	1,838
Sales	12
Shares in Float	6.54
No of funds	15
Yield	0.89

Book Value	2.11
U/D Vol ratio	1
LTDebt / Equity
Alpha	0.11
Beta	1.11